Follow
Tumor Microenvironment
Tumor Microenvironment: is the cellular environment in which non-cancerous cells are present in the tumor. This environment including surrounding blood vessels, immune cells, fibroblasts, bone marrow-derived inflammatory cells, lymphocytes, signaling molecules and the extracellular matrix .
What's Popular in Tumor Microenvironment
-
OCT 30, 2025Immunology
Scientists have developed a way to engineer immune cells that specifically target tumors. The application of engineering ...Written By: Brian G. MorrealeOCT 15, 2025Cell & Molecular Biology
3D cell cultures are no longer a futuristic idea. They’re already reshaping how we study diseases like cancer, off ...OCT 06, 2025CancerColorectal cancer is a high disease burden cancer and is the second leading cause of cancer deaths worldwide. The first- ...Sponsored By: Leica MicrosystemsOCT 06, 2025Cancer
Lymph nodes, hundreds of small structures located throughout the body, play a pivotal role in immunity, including anti-t ...Written By: Katie KokolusSEP 11, 2025Health & Medicine
Glioblastoma multiforme (GBM) is a highly aggressive and malignant brain tumor that is resistant to many treatments. Unf ...Written By: Brian G. Morreale
OCT 30, 2025
Immunology
Scientists have developed a way to engineer immune cells that specifically target tumors. The application of engineering
...
Written By:
Brian G. Morreale
OCT 15, 2025
Cell & Molecular Biology
3D cell cultures are no longer a futuristic idea. They’re already reshaping how we study diseases like cancer, off
...
OCT 06, 2025
Cancer
Colorectal cancer is a high disease burden cancer and is the second leading cause of cancer deaths worldwide. The first-
...
Sponsored By:
Leica Microsystems
OCT 06, 2025
Cancer
Lymph nodes, hundreds of small structures located throughout the body, play a pivotal role in immunity, including anti-t
...
Written By:
Katie Kokolus
SEP 11, 2025
Health & Medicine
Glioblastoma multiforme (GBM) is a highly aggressive and malignant brain tumor that is resistant to many treatments. Unf
...
Written By:
Brian G. Morreale
SEP 11, 2025
Immunology
Breast cancer is one of the most common cancers among American women. It is estimated that within the United States, abo
...
Written By:
Brian G. Morreale
JUL 10, 2025
Immunology
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells k
...
Written By:
Brian G. Morreale
JUN 17, 2025
Cancer
Spatial biology has emerged as a highly valuable field of study, examining the relationships between biological cells an
...
Written By:
Katie Kokolus
JUN 05, 2025
Immunology
According to the American Cancer Society, breast cancer is the most common cancer in women in the United States. Every 1
...
Written By:
Brian G. Morreale
-
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...NOV 05, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
NOV 05, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
On Demand
C.E. CREDITS
Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer pati...
NOV 19, 2024 | 8:00 AM
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
Speaker:
Troy Bloom
, Tanni Rahman, PhD
, Tracy Guido
, Derek Papalegis
NOV 07, 2024 | 8:00 AM
High resolution surveys of the tumor microenvironment (TME) are needed to obtain a holistic portrait of the genetic, epigenetic, and cellular factors contributing to cancer progression. To t...
OCT 02, 2024 | 8:00 AM
In this webinar, discover how Dr El Ahmar utilizes the BOND RX autostainer and image analysis workflow to stain formalin-fixed paraffin-embedded (FFPE) clinical trial samples with multiplex...
-
SEP 25, 2024 | 11:30 PM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...OCT 20, 2021 | 7:00 AM PDT
A good quality process lays the foundations for quality research results. Leica Biosystems welcomes the global Life Science community to discuss the importance of focusing on “why qual...SEP 14, 2021 | 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...NOV 10, 2020 | 8:00 AM
Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models. Learn how to conduct modern cell-based assays with var...
SEP 25, 2024
| 11:30 PM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
OCT 20, 2021
| 7:00 AM PDT
A good quality process lays the foundations for quality research results. Leica Biosystems welcomes the global Life Science community to discuss the importance of focusing on “why qual...
SEP 14, 2021
| 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...
NOV 10, 2020
| 8:00 AM
Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models. Learn how to conduct modern cell-based assays with var...
10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...
10/13-14 from 1-5pm SGT
Coming to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...
SEP 29, 2020
| 6:00 AM PDT
Due to the fact that many large events and scientific conferences have been cancelled, we want to provide you with an outlet to present your research and learn from others in our community....
SEP 23, 2020
| 6:00 AM PDT
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...